RXRX
Recursion Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.42
+0.13 ▲ +3.95%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$3.40
-0.02 ▼ -0.58%
| Index | RUT | P/E | - | EPS (ttm) | -1.48 | Insider Own | 11.88% | Shs Outstand | 0.52B | Perf Week | -1.16% |
| Market Cap | 1.81B | Forward P/E | - | EPS next Y | 10.11% | Insider Trans | -2.54% | Shs Float | 0.47B | Perf Month | -7.82% |
| Enterprise Value | 1.14B | PEG | - | EPS next Q | -0.25 | Inst Own | 55.94% | Short Float | 36.2% | Perf Quarter | -28.3% |
| Income | -0.64B | P/S | 24.19 | EPS this Y | 34.26% | Inst Trans | 2.27% | Short Ratio | 7.87 | Perf Half Y | -29.48% |
| Sales | 0.07B | P/B | 1.6 | EPS next 5Y | 18.14% | ROA | -43.32% | Short Interest | 168.52M | Perf YTD | -16.38% |
| Book/sh | 2.14 | P/C | 2.42 | EPS past 3/5Y | -1.84% -22.39% | ROE | -59.54% | 52W High | -52.37% ($7.18) | Perf Year | -42.42% |
| Cash/sh | 1.42 | P/FCF | - | Sales past 3/5Y | 23.3% 79.91% | ROIC | -54.31% | 52W Low | 14.77% ($2.98) | Perf 3Y | -55.41% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 10.74% | Gross Margin | -61.96% | Volatility(W/M) | 6% 7.11% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 15.22 | Sales Y/Y TTM | 26.92% | Oper. Margin | -867.87% | ATR (14) | 0.25 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 5.5 | EPS Q/Q | 61.44% | Profit Margin | -863.35% | RSI (14) | 41.26 | Recom | 2.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.5 | Sales Q/Q | 681.74% | SMA20 | -3.24% ($3.53) | Beta | 0.98 | Target Price | $6.71 |
| Payout | - | Debt/Eq | 0.07 | Earnings | 2000000 | SMA50 | -15.13% ($4.03) | Rel Volume | 0.67 | Prev Close | $3.29 |
| Employees | 600 | LT Debt/Eq | 0.05 | EPS/Sales Surpr. | 30.33% 44.04% | SMA200 | -29.06% ($4.82) | Avg Volume(3M) | 21.42M | Price | $3.42 |
| IPO | 2021/4/16 | Option/Short | Yes/Yes | Trades | 23801 | Volume | 14,409,875 | Change | 3.95% |
뉴스 로딩 중...